发明名称 Macrocyclic hepatitis C serine protease inhibitors
摘要 MACROCYCLIC HEPATITIS C SERINE PROTEASE Abstract The present invention relates to novel macrocyclic compounds and methods of use thereof. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutical acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutical carrier or excipient.
申请公布号 AU2013205040(B2) 申请公布日期 2016.05.12
申请号 AU20130205040 申请日期 2013.04.13
申请人 ENANTA PHARMACEUTICALS, INC.;ABBVIE BAHAMAS LTD 发明人 KU, YIYIN;MCDANIEL, KEITH F.;CHEN, HUI-JU;SHANLEY, JASON P.;KEMPF, DALE J.;GRAMPOVNIK, DAVID J.;SUN, YING;LIU, DONG;YONGHUA, GAI;OR, YAT SUN;WAGAW, SABLE H.;ENGSTROM, KEN;GRIEME, TIM;SHEIKH, AHMAD;MEI, JIANZHANG
分类号 A61K38/00;A61K38/12 主分类号 A61K38/00
代理机构 代理人
主权项
地址